Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 1/20 | 0.47 |
| ▸ | SYK | P43405 | 1/20 | 0.40 |
| ▸ | PRKCQ | Q04759 | 3/20 | 0.39 |
| ▸ | AHR | P35869 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | ROCK2 | O75116 | 6/20 | 0.37 |
| ▸ | ESR1 | P03372 | 3/20 | 0.36 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29330253 | 0.90 | EGFR (0.41) | METSYKPRKCQAHRESR1 | |
| SCHEMBL29329719 | 0.90 | MET (0.41) | METSYKPRKCQROCK2ESR1 | |
| SCHEMBL29329440 | 0.89 | MET (0.40) | METSYKPRKCQAHRROCK2 | |
| SCHEMBL29330255 | 0.89 | ESR1 (0.42) | METSYKPRKCQAHRESR1 | |
| SCHEMBL29329283 | 0.89 | MET (0.42) | METSYKPRKCQROCK2ESR1 | |
| SCHEMBL29330031 | 0.89 | MET (0.42) | METSYKPRKCQAHRESR1 | |
| SCHEMBL29329639 | 0.87 | MET (0.43) | METSYKPRKCQAHRTRPA1 | |
| SCHEMBL29330251 | 0.87 | SYK (0.41) | METSYKPRKCQAHRESR1 | |
| SCHEMBL29330032 | 0.86 | SYK (0.42) | METSYKPRKCQAHRESR1 | |
| SCHEMBL29330254 | 0.85 | SYK (0.42) | METSYKPRKCQTRPA1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151919-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM DUE, INC. (US) | 2024-07-18 | — | — | WO | disclosed |